Evidence of unexpected oxidative stress in airways of adolescents born very pre-term

European Respiratory Journal

Volumn 40, Issue 5, 2012, Pages 1253-1259

  Filippone, Marco ^a   Bonetto, Gea ^a   Corradi, Massimo ^b   Frigo, Anna Chiara ^a   Baraldi, Eugenio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

8 isoprostane; Bronchopulmonary dysplasia; Exhaled breath condensate; Prematurity

Indexed keywords

8 ISOPROSTANE; BIOLOGICAL MARKER; NITRIC OXIDE;

ADOLESCENT; ARTICLE; CONTROLLED STUDY; COUGHING; DISEASE ASSOCIATION; EXHALATION; FEMALE; FORCED EXPIRATORY VOLUME; GESTATIONAL AGE; HUMAN; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PREMATURITY; PRICK TEST; PRIORITY JOURNAL; SKIN TEST; SPIROMETRY; SYMPTOMATOLOGY; WHEEZING;

ADOLESCENT; BIOLOGICAL MARKERS; BREATH TESTS; BRONCHOPULMONARY DYSPLASIA; DINOPROST; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; OXIDATIVE STRESS; RESPIRATORY SYSTEM;

EID: 84865715084     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00185511     Document Type: Article

References (40)

1. Muglia LJ, Katz M. The enigma of spontaneous preterm birth. N Engl J Med 2010; 362: 529-535.
2. Kinsella JP, Greenough A, Abman SH. Bronchopulmonary dysplasia. Lancet 2006; 367: 1421-1431.
3. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723-1729.
4. Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med 2007; 357: 1946-1955.
5. Narang I, Rosenthal M, Cremonesini D, et al. Longitudinal evaluation of airway function 21 years after preterm birth. Am J Respir Crit Care Med 2008; 178: 74-80.
6. Walter EC, Ehlenbach WJ, Hotchkin DL, et al. Low birth weight and respiratory disease in adulthood: a population-based case-control study. Am J Respir Crit Care Med 2009; 180: 176-180.
7. Doyle LW, Faber B, Callanan C, et al. Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence. Pediatrics 2006; 118: 108-113.
8. Halvorsen T, Skadberg BT, Eide GE, et al. Pulmonary outcome in adolescents of extreme preterm birth: a regional cohort study. Acta Paediatr 2004; 93: 1294-1300.
9. Northway WH Jr, Moss RB, Carlisle KB, et al. Late pulmonary sequelae of bronchopulmonary dysplasia. N Engl J Med 1990; 323: 1793-1799.
10. Bush A. COPD: a pediatric disease. COPD 2008; 5: 53-67.
11. Vestbo J, Rennard S. Chronic obstructive pulmonary disease biomarker(s) for disease activity needed-urgently. Am J Respir Crit Care Med 2010; 182: 863-864.
12. MacNee W, Tuder RM. New paradigms in the pathogenesis of chronic obstructive pulmonary disease I. Proc Am Thorac Soc 2009; 6: 527-531.
13. Saugstad OD. Oxygen and oxidative stress in bronchopulmonary dysplasia. J Perinat Med 2010; 38: 571-577.
14. Lee JW, Davis JM. Future applications of antioxidants in premature infants. Curr Opin Pediatr 2011; 23: 161-166.
15. Wright CJ, Dennery PA. Manipulation of gene expression by oxygen: a primer from bedside to bench. Pediatr Res 2009; 66: 3-10.
16. Vento M, Moro M, Escrig R, et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics 2009; 124: e439-e449.
17. Borrill ZL, Roy K. K, Singh D. Exhaled breath condensate biomarkers in COPD. Eur Respir J 2008; 32: 472-486.
18. Montuschi P, Barnes PJ, Ciabattoni G. Measurement of 8-isoprostane in exhaled breath condensate. Methods Mol Biol 2010; 594: 73-84.
19. Horváth I, Hunt J, Barnes PJ, et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005; 26: 523-548.
20. Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respiratory therapy of hyaline-membrane disease: bronchopulmonary dysplasia. N Engl J Med 1967; 276: 357-368.
21. Goldoni M, Caglieri A, Andreoli R, et al. Influence of condensation temperature on selected exhaled breath parameters. BMC Pulm Med 2005; 5: 10.
22. Caglieri A, Goldoni M, Acampa O, et al. The effect of inhaled chromium on different exhaled breath condensate biomarkers among chrome-plating workers. Environ Health Perspect 2006; 114: 542-546.
23. Carraro S, Cogo PE, Isak I, et al. EIA and GC/MS analysis of 8-isoprostane in EBC of children with problematic asthma. Eur Respir J 2010; 5: 1364-1369.
24. Zanconato S, Carraro S, Corradi M, et al. Leukotrienes and 8-isoprostane in exhaled breath condensate of children with stable and unstable asthma. J Allergy Clin Immunol 2004; 113: 257-263.
25. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
26. Stanojevic S, Wade A, Cole TJ, et al. Spirometry centile charts for young Caucasian children: the Asthma UK Collaborative Initiative. Am J Respir Crit Care Med 2009; 180: 547-552.
27. Baraldi E, de Jongste JC, European Respiratory Society/American Thoracic Society Task Force. Measurement of exhaled nitric oxide in children, 2001. Eur Respir J 2002; 20: 223-237.
28. Lum S, Kirkby J, Welsh L, et al. Nature and severity of lung function abnormalities in extremely preterm children at 11 years of age. Eur Respir J 2011; 37: 1199-1207.
29. Latzin P, Roth S, Thamrin C, et al. Lung volume., breathing pattern and ventilation inhomogeneity in preterm and term infants. PLoS One 2009; 4: e4635.
30. Martinez FD. The origins of asthma and chronic obstructive pulmonary disease in early life. Proc Am Thorac Soc 2009; 6: 272-277.
31. Haland G, Carlsen KC, Sandvik L, et al. Reduced lung function at birth and the risk of asthma at 10 years of age. N Engl J Med 2006; 355: 1682-1689.
32. Stern DA, Morgan WJ, Wright AL, et al. Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet 2007; 370: 758-764.
33. Filippone M, Bonetto G, Cherubin E, et al. Childhood course of lung function in survivors of bronchopulmonary dysplasia. JAMA 2009; 302: 1418-1420.
34. Effros RM. Exhaled breath condensate: delusion or dilution? Chest 2010; 138: 471-472.
35. Montuschi P. Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications. Ther Adv Respir Dis 2007; 1: 5-23.
36. Morrow JD, Roberts LJ. The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease. Am J Respir Crit Care Med 2002; 166: S25-S30.
37. Baraldi E, Bonetto G, Zacchello F, et al. Low exhaled nitric oxide in school-age children with bronchopulmonary dysplasia and airflow limitation. Am J Respir Crit Care Med 2005; 171: 68-72.
38. Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FeNO) for clinical applications. Am J Respir Crit Care Med 2011; 184: 602-615.
39. Agusti A, MacNee W, Donaldson K, et al. Hypothesis: does COPD have an autoimmune component? Thorax 2003; 58: 832-834.
40. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009; 360: 2445-2454.